| |
Total |
Negative |
Positive |
p value |
| |
|
n (%) |
n (%) |
|
| Gender |
|
|
|
|
|
|
| Males |
43 |
18 |
(42) |
25 |
(58) |
|
| Females |
25 |
11 |
(44) |
14 |
(56) |
n.s. |
| Age (yr) |
|
|
|
|
|
|
| £ 62 ° |
34 |
11 |
(32) |
23 |
(68) |
|
| > 62 |
34 |
18 |
(53) |
16 |
(47) |
n.s. |
| Tumor Grading |
|
|
|
|
|
|
| 1 |
22 |
8 |
(36) |
14 |
(64) |
|
| 2 |
27 |
13 |
(48) |
14 |
(52) |
|
| 3 |
19 |
8 |
(42) |
11 |
(58) |
ns |
| Tumor Stage |
|
|
|
|
|
|
| pT1 |
10 |
6 |
(60) |
4 |
(40) |
|
| pT2 |
15 |
10 |
(66) |
5 |
(34) |
|
| pT3 |
6 |
1 |
(17) |
5 |
(83) |
|
| pT4 |
37 |
12 |
(32) |
25 |
(68) |
0.04 |
| Nodal status |
|
|
|
|
|
|
| Negative |
30 |
18 |
(60) |
12 |
(40) |
|
| Positive |
38 |
11 |
(29) |
27 |
(71) |
0.01 |
|
